SCHEMBL30722374

SCHEMBL30722374

CCn1cc(-c2cccc(N)c2)nn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 5/20 0.57
KDR P35968 4/20 0.57
EPHB4 P54760 2/20 0.54
UCHL5 Q9Y5K5 2/20 0.49
PRMT5 O14744 1/20 0.49
CYP19A1 P11511 1/20 0.44
UCHL1 P09936 1/20 0.44
UCHL3 P15374 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALOX5 P09917 1/20 0.42
TSHR P16473 1/20 0.42
RECQL P46063 1/20 0.42
MECP2 P51608 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16264699 1.00 TEK (0.57) TEKKDREPHB4UCHL5PRMT5
SCHEMBL14987759 0.88 TEK (0.55) TEKKDREPHB4UCHL5PRMT5
SCHEMBL16263152 0.84 TEK (0.54) TEKKDREPHB4UCHL5PRMT5
SCHEMBL18625808 0.84 PRMT5 (0.55) TEKKDREPHB4UCHL5PRMT5
SCHEMBL22868173 0.83 KDR (0.59) TEKKDREPHB4CYP19A1NPC1
SCHEMBL28311174 0.81 TEK (0.55) TEKKDREPHB4UCHL5PRMT5
SCHEMBL22868183 0.81 ROCK2 (0.47) TEKKDREPHB4CYP19A1NPC1
SCHEMBL19535294 0.81 KDR (0.57) TEKKDREPHB4CYP19A1NPC1
SCHEMBL18760619 0.81 ALOX5 (0.56) TEKKDREPHB4CYP19A1NPC1
SCHEMBL28593627 0.81 CYP19A1 (0.72) TEKKDREPHB4UCHL5CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117355512-A Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer 托雷莫治疗股份公司 2024-01-05 CN disclosed